Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 1
2005 4
2006 2
2007 3
2008 4
2009 4
2010 5
2011 3
2012 2
2013 4
2014 5
2015 11
2016 14
2017 13
2018 9
2019 10
2020 6
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy.
Li JY, Perry SR, Muniz-Medina V, Wang X, Wetzel LK, Rebelatto MC, Hinrichs MJ, Bezabeh BZ, Fleming RL, Dimasi N, Feng H, Toader D, Yuan AQ, Xu L, Lin J, Gao C, Wu H, Dixit R, Osbourn JK, Coats SR. Li JY, et al. Among authors: wu h. Cancer Cell. 2016 Jan 11;29(1):117-29. doi: 10.1016/j.ccell.2015.12.008. Cancer Cell. 2016. PMID: 26766593 Free article.
Tailor-made antibody therapeutics.
Chowdhury PS, Wu H. Chowdhury PS, et al. Among authors: wu h. Methods. 2005 May;36(1):11-24. doi: 10.1016/j.ymeth.2005.01.002. Methods. 2005. PMID: 15848071 Review.
Humanized antibodies and their applications.
Wu H, Dall'Acqua WF. Wu H, et al. Methods. 2005 May;36(1):1-2. doi: 10.1016/j.ymeth.2005.02.001. Methods. 2005. PMID: 15848069 No abstract available.
Long-acting antibody ligand mimetics for HER4-selective agonism.
Shan L, Cook KM, Haskins N, Omar B, Jiang Y, Garcia A, Koksal A, Oganesyan V, Rosenthal K, Wu H, Dall'Acqua WF, Damschroder MM. Shan L, et al. Among authors: wu h. Sci Rep. 2020 Oct 14;10(1):17257. doi: 10.1038/s41598-020-74176-9. Sci Rep. 2020. PMID: 33057063 Free PMC article.
Immunotherapies against antibiotics-resistant Klebsiella pneumoniae.
Xiao X, Wu H, Dall'Acqua WF. Xiao X, et al. Among authors: wu h. Hum Vaccin Immunother. 2016 Dec;12(12):3097-3098. doi: 10.1080/21645515.2016.1210746. Epub 2016 Jul 18. Hum Vaccin Immunother. 2016. PMID: 27431874 Free PMC article. No abstract available.
Metabolite-Based Modification of Poly(l-lysine) for Improved Gene Delivery.
Urello MA, Xiang L, Colombo R, Ma A, Joseph A, Boyd J, Peterson N, Gao C, Wu H, Christie RJ. Urello MA, et al. Among authors: wu h. Biomacromolecules. 2020 Sep 14;21(9):3596-3607. doi: 10.1021/acs.biomac.0c00614. Epub 2020 Aug 18. Biomacromolecules. 2020. PMID: 32786528
Enhancement of antibody functions through Fc multiplications.
Wang Q, Chen Y, Pelletier M, Cvitkovic R, Bonnell J, Chang CY, Koksal AC, O'Connor E, Gao X, Yu XQ, Wu H, Stover CK, Dall'Acqua WF, Xiao X. Wang Q, et al. Among authors: wu h. MAbs. 2017 Apr;9(3):393-403. doi: 10.1080/19420862.2017.1281505. Epub 2017 Jan 19. MAbs. 2017. PMID: 28102754 Free PMC article.
105 results